Calsoft story began in Chennai, India in 1992
A strategy for the challenges and opportunities in all businesses is hurt by COVID-19, now, Calsoft is adapting and preparing for the post-COVID-19 world, and adjusting to its environment to maintain and strengthen its enduring partnerships with clients, just as it has always done over the past 25 years.
This pandemic will lead to clients accelerating their shift to operating with digital business models. Due to the changes resulting from digital transformation, business related issues are becoming increasingly significant within the digital services market and see ample headroom for growth in developing digital engineering, artificial intelligence (AI) and analytics, intelligent process automation, Cloud and IoT.
Acquisitions are essential to building critical skills and capabilities in strategic, high-growth areas. From 2017 onwards, Calsoft is in the process of acquiring E Commerce, AI and machine learning startups, Clinical data processing and management companies.
Large customers in key industries globally have moved from the concept of digital transformation to actual implementation. In this round of construction, India’s software service companies have gained first-mover advantages. These changes will become Calsoft’s opportunities to “overtake” its peers.
“Sailing on the same Boat Strategy” headwind to build CS-Digital
Calsoft is in the process of developing and launching a “cloud-based software industry park”. CS-Digital, to support small IT Enterprises, gather software service ecosystem, enhance the efficiency of local software industry, and support transformation and upgrading and innovation development of traditional enterprises.
“Shares the Same boat” Cs-Cloud Computing
CsDigital will co-construct a new ecosystem for ITS industry Cs-Cloud. Calsoft’s goal is to become a strategic partner that “shares the same boat”.
“Breakthrough in Bottlenecks” Cs-BigData
The premier global market intelligence firm predicts that the big data and analytic market will grow from USD130 billion to USD203 billion from 2016 to 2020.
EYWA - AI assistant for Doctors
EYWA redefine the way people access healthcare.
Cs-eCom - Digital Transformation of E Commerce Solutions by AI Integration
By 2020, more than 80 percent of e-commerce applications would be integrated with AI. Cs-eCom is an open and flexible framework to keep up with this growing list of emerging capabilities with AI integrations. Cs-eCom can be used to trade B2B (business-to-business) and B2C(business-to-customer) segments.
CS-eCom is Digital e Commerce platform provides the power to create unique and engaging shopping experiences. Recent research from McKinsey shows that 96% of surveyed B2B and B2C businesses have, in fact, changed their sales model to favor online and eCommerce-based selling. On average, this shift has proved fruitful, migration in shopper behaviour to digital commerce has also been persistent.
Calsoft is fortunate to be surrounded by a deeply experienced leadership team, a fully engaged Board of Directors, and passionate employees.
Calsoft are at new starting point to achieve its vision and mission, with core values “Keeping True Heart of Kindness, Determination and Perseverance, Striving for Success, Sharing and Growing with the Customers” that leads to great accomplishment.
1992 - Year of incorporation
1996 - Listed on major stock exchanges in India
2004 - Acquired 100% stake in Webspectrum Software Ltd., Bangalore, India
2005 - SEI-CMMi Level 5 certification Acquired majority holding in Informed Decisions Corp., Alameda. CA
2005 - Acquired majority holding in American HealthNet (AHN) Omaha, Nebraska Set up office in Dubai, UAE
2006- Acquired majority stake in Inatech Infosolutions , London, UK & Bangalore, India
2007 - Acquired majority stake in Aspire Communications Mysore, India & San Jose, USA
2008 - Completed 100% acquisition of Inatech Infosolutions.
2008- Acquired 100% stake in International Innovations Inc., USA
Dr. Vasudevan Mahalingam
Managing Director and CEO
Vijay Madavan. B. Tech, MBA.,
Director - Technical
Dr. M. Ravichandran
Director - International Operations (USA)
Dr. RS. Chandan, M.Pharm., PhD
Dr. V. Manimala
Director - Clinical Research
Dr. Murugan Vadivel
Director - IT (USA)
Director - Research
Dr. B. Duraisamy
Director - Innovation